CORC

在结果中检索

CORC

浏览/检索结果: 共17条，第1-10条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Contextual Stroke Classification in Online Handwritten Documents with Graph Attention Networks 会议论文
澳大利亚,悉尼, 2019-9
作者:  Jun-Yu Ye;  Yan-Ming Zhang;  Qing Yang;  Cheng-Lin Liu
收藏  |  浏览/下载：13/0  |  提交时间：2021/03/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
A pretargeted imaging strategy for immune checkpoint ligand PD-L1 expression in tumor based on bioorthogonal Diels-Alder click chemistry 会议论文
作者:  Qiu, Lin;  Lin, Qingyu;  Si, Zzhan;  Tan, Hui;  Mao, Wujian
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria 会议论文
作者:  Gu Wenyi;  Deng, Guohong;  Zheng, Xin;  Chen, Jinjun;  Wang, Xian-bo
收藏  |  浏览/下载：90/0  |  提交时间：2019/12/05
Plasma Concentration of Perfluoroalkyl Substances and Risk of Idiopathic Recurrent Spontaneous Abortion: A Multicenter Case-Control Study in China. 会议论文
作者:  Huo, Xiaona;  Luo, Kai;  Ye, Jiangfeng;  Chen, Lin
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Thermochemical behavior and kinetic analysis during co-pyrolysis of starch biomass model compound and lignite 会议论文
INNOVATIVE SOLUTIONS FOR ENERGY TRANSITIONS, 2019-01-01
作者:  Meng, Haiyu;  Wang, Shuzhong;  Wu, Zhiqiang;  Zhao, Jun;  Chen, Lin
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/20

©版权所有 ©2017 CSpace - Powered by CSpace